There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
Latest posts by Hippocratic Post (see all)
- Lab-Grown Mini Organs to Speed Up Disease Treatments - 17th May 2024
- Eight CSR Ways to Boost Wellbeing for Mental Health Week 2024 - 14th May 2024
- New super-pure silicon chip opens path to powerful quantum computers - 9th May 2024